首页 > 市场调查报告书 > 製药

疫苗感染疾病

欧洲疟疾治疗市场预测至 2030 年 - 区域分析 - 按治疗、给药途径和配销通路

市场调查报告书

商品编码

1510758

欧洲疟疾治疗市场预测至 2030 年 - 区域分析 - 按治疗、给药途径和配销通路

Europe Malaria Treatment Market Forecast to 2030 - Regional Analysis - by Treatment, Route of Administration, and Distribution Channel

出版日期: 2024年05月07日 | 出版商:

The Insight Partners | 英文 87 Pages | 订单完成后即时交付

价格

简介目录图表

2022年欧洲疟疾治疗市值为4.5169亿美元，预计2030年将达到30.6097亿美元；预计2022年至2030年复合年增长率为27.0%。

扩大新药和疫苗研发线推动欧洲疟疾治疗市场

抗生素抗药性会使大众面临许多疾病的风险，例如疟疾。为了克服这个挑战，新药的研发被认为是最好的策略；因此，抗疟药物管道变得越来越强大。公私伙伴关係正在加速与疟疾治疗相关的研究活动。例如，非营利组织 Medicines for Malaria Venture (MMV) 与众多製药公司合作，透过开发新的治疗方案来减轻疟疾的负担。

下表提到了一些正在临床上开发的抗疟药：

表 1. 临床开发中的疟疾药物/疫苗/化合物

药物开发商临床试验阶段

Artefenomel 赛诺菲 IIb 期

KAE609 诺华公司 IIb 期

KAF156 诺华公司 IIb 期

DSM265武田製药公司IIa期

SANARIA PfSPZ-GA1 Sanaria 二期

SANARIA PfSPZ 疫苗 - 辐射减毒 PfSPZ 疫苗 Sanaria II 期

SANARIA PfSPZ-CVac Sanaria 二期

MSP3-CRM-Vac4All Vac4All 第一阶段

肝期抗原 3 (LSA3) Vac4All IIa 期

资料来源：公司网站、Insight Partners 分析

因此，临床开发中的抗疟药和药物/疫苗数量的增加预计将推动未来市场的成长。

欧洲疟疾治疗市场概况

根据ECDC的监测报告，法国报告2020年疟疾病例数最高。 2020年欧盟/欧洲经济区国家报告的几乎所有病例都是从其他国家前往法国的人中确诊的；这些人主要包括与西非旅行路线有关的个人。在法国，恶性疟原虫几乎是旅行者中所有严重病例和死亡的罪魁祸首。许多研究组织正在努力开发新方法来消除法国的疟疾。例如，巴斯德研究所的团队致力于疟疾研究，旨在开发疫苗。这项研究对于寻找对抗疟疾的新方法至关重要。巴斯德研究所还参加了一项名为 EVIMalaR 的欧洲重大项目，该项目涉及来自 7 个欧洲国家的 17 个研究机构和大学以及来自 3 个非洲国家的合作伙伴。这种消除疟疾的合作努力正在推动法国疟疾治疗市场的成长。

欧洲疟疾治疗市场收入及 2030 年预测（百万美元）

欧洲疟疾治疗市场细分

欧洲疟疾治疗市场根据治疗、给药途径、配销通路和国家进行细分。根据治疗方法，欧洲疟疾治疗市场分为仿製药、原厂药、疫苗等。 2022 年，仿製药细分市场占最大市场份额。

就给药途径而言，欧洲疟疾治疗市场分为口服和肠外给药。 2022年，口腔细分市场占据了更大的市场。

依配销通路，欧洲疟疾治疗市场分为直接招标、医院药局、零售药局、线上药局等。 2022 年，直接招标领域占据最大的市场份额。

根据国家/地区，欧洲疟疾治疗市场分为英国、德国、法国、义大利、西班牙和欧洲其他地区。 2022 年，法国在欧洲疟疾治疗市场份额中占据主导地位。

Cipla Ltd、Sun Pharmaceutical Industries Ltd、赛诺菲 SA、GSK Plc、诺华 AG、辉瑞 Inc 和 Lupin Ltd 是欧洲疟疾治疗市场的一些领先参与者。

Antimicrobial resistance can put the public at risk of many diseases, such as malaria. To overcome this challenge, the R&D of new medicines is considered the best strategy; as a result, the antimalarial pipeline is becoming increasingly robust. Public-private partnerships are accelerating research activities related to the treatment of malaria. For instance, Medicines for Malaria Venture (MMV), a nonprofit organization, works with numerous pharmaceutical companies to reduce the burden of malaria by developing novel treatment options.

A few antimalarial that are under clinical development are mentioned in the table below:

Table 1. Malaria Drugs/Vaccine/Compounds Under Clinical Development

Drug Developer Clinical Trial Stage

Artefenomel Sanofi Phase IIb

KAE609 Novartis AG Phase IIb

KAF156 Novartis AG Phase IIb

DSM265 Takeda Pharmaceutical Company Phase IIa

SANARIA PfSPZ-GA1 Sanaria Phase II

SANARIA PfSPZ Vaccine - Radiation Attenuated PfSPZ Vaccine Sanaria Phase II

SANARIA PfSPZ-CVac Sanaria Phase II

MSP3-CRM-Vac4All Vac4All Phase I

Liver-Stage Antigen-3 (LSA3) Vac4All Phase IIa

Source: Company Website, The Insight Partners Analysis

Therefore, the growing number of antimalarial and drugs/vaccines that are under clinical development are expected to boost the market growth in the future.

Europe Malaria Treatment Market Overview

According to a surveillance report by ECDC, France reported the highest number of malaria cases in 2020. In 2020, France reported 1,007 confirmed malaria cases. Nearly all the cases reported by EU/EEA countries in 2020 were diagnosed in people traveling to France from other countries; these mostly included individuals linked to travel routes from West Africa. In France, P. falciparum is responsible for almost all severe cases and deaths in travelers. Many research organizations are working toward developing new approaches to eliminate malaria in France. For example, teams at the Institut Pasteur are dedicated to malaria research aiming to develop vaccines. This research is vital in finding new ways of fighting malaria. The Institute Pasteur is also taking part in a major European program named EVIMalaR, which involves 17 research institutes and universities from 7 European countries, and partners from 3 African countries. Such collaborative efforts toward malaria elimination are driving the growth of the malaria treatment market in France.

Europe Malaria Treatment Market Revenue and Forecast to 2030 (US$ Million)

Europe Malaria Treatment Market Segmentation

The Europe malaria treatment market is segmented based on treatment, route of administration, distribution channel, and country. Based on treatment, the Europe malaria treatment market is segmented into generic drugs, originators, vaccines, and others. The generic drugs segment held the largest market share in 2022.

In terms of route of administration, the Europe malaria treatment market is bifurcated into oral and parenteral. The oral segment held a larger market share in 2022.

By distribution channel, the Europe malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. The direct tender segment held the largest market share in 2022.

Based on country, the Europe malaria treatment market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. France dominated the Europe malaria treatment market share in 2022.

Cipla Ltd, Sun Pharmaceutical Industries Ltd, Sanofi SA, GSK Plc, Novartis AG, Pfizer Inc, and Lupin Ltd are some of the leading players operating in the Europe malaria treatment market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights - Malaria

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Malaria Treatment Market - Key Industry Dynamics

4.1 Key Market Drivers:
- 4.1.1 Increasing Prevalence of Malaria
4.2 Market Restraints
- 4.2.1 Availability of Counterfeit Antimalarial Drugs Followed by Subsequent Drug Resistance
4.3 Market Opportunities
- 4.3.1 Growing Strategic Initiatives by Market Players
4.4 Future Trends
- 4.4.1 Extending Pipeline of New Drugs and Vaccines
4.5 Impact Analysis

5. Malaria Treatment Market - Europe Market Analysis

5.1 Europe Malaria Treatment Market Revenue (US$ million), 2022 - 2030

6. Europe Malaria Treatment Market - Revenue and Forecast to 2030 - by Treatment

6.1 Overview
6.2 Europe Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
6.3 Vaccines
- 6.3.1 Overview
- 6.3.2 Vaccines Market Revenue and Forecast to 2030 (US$ Mn)
6.4 Generic Drugs
- 6.4.1 Overview
- 6.4.2 Generic Drugs Market Revenue and Forecast to 2030 (US$ Mn)
6.5 Originators
- 6.5.1 Overview
- 6.5.2 Originators Market Revenue and Forecast to 2030 (US$ Mn)
6.6 Others
- 6.6.1 Overview
- 6.6.2 Others Market Revenue and Forecast to 2030 (US$ Mn)

7. Europe Malaria Treatment Market - Revenue and Forecast to 2030 - by Route of Administration

7.1 Overview
7.2 Europe Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
7.3 Oral
- 7.3.1 Overview
- 7.3.2 Oral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Parenteral
- 7.4.1 Overview
- 7.4.2 Parenteral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Malaria Treatment Market - Revenue and Forecast to 2030 - by Distribution Channel

8.1 Overview
8.2 Europe Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
8.3 Direct Tender
- 8.3.1 Overview
- 8.3.2 Direct Tender: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Hospital Pharmacies
- 8.4.1 Overview
- 8.4.2 Hospital Pharmacies: Malaria Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Retail Pharmacies
- 8.5.1 Overview
- 8.5.2 Retail Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Online Pharmacies
- 8.6.1 Overview
- 8.6.2 Online Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Malaria Treatment Market - Country Analysis

9.1 Europe Malaria Treatment Market, Revenue and Forecast to 2030
- 9.1.1 Overview
  - 9.1.1.1 Europe: Malaria Treatment Market, by Countries
  - 9.1.1.2 France
  - 9.1.1.3 Overview
    - 9.1.1.3.1 France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.1.1.3.2 France: Malaria Treatment Market, by Treatment
    - 9.1.1.3.3 France: Malaria -Malaria Treatment Market, by Route of Administration
    - 9.1.1.3.4 France: Malaria Treatment Market, by Distribution Channel
    - 9.1.1.3.4.1 France: Malaria Treatment Market, by Hospital Pharmacies
    - 9.1.1.3.4.2 France: Malaria Treatment Market, by Retail Pharmacies
  - 9.1.1.4 UK
  - 9.1.1.5 Overview
    - 9.1.1.5.1 UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.1.1.5.2 UK: Malaria Treatment Market, by Treatment
    - 9.1.1.5.3 UK: Malaria -Malaria Treatment Market, by Route of Administration
    - 9.1.1.5.4 UK: Malaria Treatment Market, by Distribution Channel
    - 9.1.1.5.4.1 UK: Malaria Treatment Market, by Hospital Pharmacies
    - 9.1.1.5.4.2 UK: Malaria Treatment Market, by Retail Pharmacies
  - 9.1.1.6 Italy
  - 9.1.1.7 Overview
    - 9.1.1.7.1 Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.1.1.7.2 Italy: Malaria Treatment Market, by Treatment
    - 9.1.1.7.3 Italy: Malaria -Malaria Treatment Market, by Route of Administration
    - 9.1.1.7.4 Italy: Malaria Treatment Market, by Distribution Channel
    - 9.1.1.7.4.1 Italy: Malaria Treatment Market, by Hospital Pharmacies
    - 9.1.1.7.4.2 Italy: Malaria Treatment Market, by Retail Pharmacies
  - 9.1.1.8 Germany
  - 9.1.1.9 Overview
    - 9.1.1.9.1 Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.1.1.9.2 Germany: Malaria Treatment Market, by Treatment
    - 9.1.1.9.3 Germany: Malaria -Malaria Treatment Market, by Route of Administration
    - 9.1.1.9.4 Germany: Malaria Treatment Market, by Distribution Channel
    - 9.1.1.9.4.1 Germany: Malaria Treatment Market, by Hospital Pharmacies
    - 9.1.1.9.4.2 Germany: Malaria Treatment Market, by Retail Pharmacies
  - 9.1.1.10 Spain
  - 9.1.1.11 Overview
    - 9.1.1.11.1 Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.1.1.11.2 Spain: Malaria Treatment Market, by Treatment
    - 9.1.1.11.3 Spain: Malaria -Malaria Treatment Market, by Route of Administration
    - 9.1.1.11.4 Spain: Malaria Treatment Market, by Distribution Channel
    - 9.1.1.11.4.1 Spain: Malaria Treatment Market, by Hospital Pharmacies
    - 9.1.1.11.4.2 Spain: Malaria Treatment Market, by Retail Pharmacies
  - 9.1.1.12 Rest of Europe
  - 9.1.1.13 Overview
    - 9.1.1.13.1 Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.1.1.13.2 Rest of Europe: Malaria Treatment Market, by Treatment
    - 9.1.1.13.3 Rest of Europe: Malaria -Malaria Treatment Market, by Route of Administration
    - 9.1.1.13.4 Rest of Europe: Malaria Treatment Market, by Distribution Channel
    - 9.1.1.13.4.1 Rest of Europe: Malaria Treatment Market, by Hospital Pharmacies
    - 9.1.1.13.4.2 Rest of Europe: Malaria Treatment Market, by Retail Pharmacies

10. Malaria Treatment Market Industry Landscape

10.1 Overview
10.2 Growth Strategies in the Malaria Treatment Market
10.3 Inorganic Growth Strategies
- 10.3.1 Overview
10.4 Organic Growth Strategies
- 10.4.1 Overview

11. Company Profiles

11.1 Cipla Ltd
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Sun Pharmaceutical Industries Ltd
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Sanofi SA
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 GSK Plc
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Novartis AG
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Pfizer Inc
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Service
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Lupin Ltd
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments

12. Appendix

12.1 About Us
12.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. Malaria Treatment Market Segmentation
Table 2. Malaria Drugs/Vaccine/Compounds Under Clinical Development
Table 3. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 4. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 5. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 6. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 7. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 8. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 9. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 10. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 11. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 12. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 13. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 14. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 15. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 16. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 17. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 18. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 19. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 20. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 21. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 22. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 23. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 24. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 25. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 26. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 27. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 28. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 29. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 30. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 31. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 32. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 33. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 34. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 35. Recent Inorganic Growth Strategies in the Malaria Treatment Market
Table 36. Recent Organic Growth Strategies in the Malaria Treatment Market
Table 37. Glossary of Terms, Malaria Treatment Market

List Of Figures

Figure 1. Malaria Treatment Market - Key Industry Dynamics
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Europe Malaria Treatment Market Revenue (US$ million), 2022 - 2030
Figure 4. Europe Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
Figure 5. Vaccines Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 6. Generic Drugs Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 7. Originators Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 8. Others Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 9. Europe Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
Figure 10. Oral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Parenteral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Europe Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
Figure 13. Direct Tender: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Hospital Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Retail Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Online Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Europe Malaria Treatment Market, By Country, 2022 ($Mn)
Figure 19. Europe: Malaria Treatment Market, By Key Countries, 2022 and 2030 (%)
Figure 20. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 21. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 22. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 23. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 24. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. Growth Strategies in the Malaria Treatment Market